RFK Jr.’s team wanted to tout an autism therapy. But a meeting with Tylenol’s maker convinced the U.S. health secretary to put the emphasis on acetaminophen
NeutralU.S News

In a recent meeting, RFK Jr.'s team aimed to promote an autism therapy but shifted focus after discussions with the maker of Tylenol. The U.S. health secretary was persuaded to highlight the risks associated with acetaminophen instead of leucovorin, which had been the initial focus of health agencies. This change underscores the ongoing debate about the safety of common medications and their potential links to health issues, particularly in children.
— Curated by the World Pulse Now AI Editorial System